Ionis Pharmaceuticals in (ions 0 04/01/26)
13F holders, Q2 2024 (June 30)9holders +1
1new positions
0sold out
$1.01avg. 13F price*
At the end of Q2 2024, 9 institutions reported holding Ionis Pharmaceuticals in (ions 0 04/01/26) in their 13F filings, up 1 from Q1 2024. 1 opened new positions and 0 sold out. The largest holders were Sonora Investment Management Group, LLC ($12.4M), Toronto Dominion Bank ($6.2M) and Jane Street Group, LLC ($561K).
- Company
- Ionis Pharmaceuticals in (ions 0 04/01/26)
- CUSIP
- 462222AD2
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $43K |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 589,000 shares bought and 1,076,000 shares sold, net −487,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Sonora Investment Management Group, LLC | 0.98% | No change | 12,518,000 | $12.4M |
| Toronto Dominion Bank | 0.01% | Add +9.1% | 6,000,000 | $6.2M |
| Jane Street Group, LLC | 0.00% | Reduce -51.3% | 545,000 | $561K |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.00% | No change | 500,000 | $514K |
| Bank of New York Mellon Corp | 0.00% | Reduce -62.5% | 300,000 | $309K |
| Sei Investments Co. | 0.00% | No change | 259,000 | $267K |
| Oppenheimer Asset Management Inc. | 0.00% | Add +83.9% | 103,000 | $106K |
| Stephens Inc. | 0.00% | Reduce -2.0% | 48,000 | $49K |
| Choreo, LLC | 0.00% | New | 42,000 | $43K |
"% of holder's portfolio" is IONIS PHARMACEUTICALS IN (IONS 0 04/01/26)'s weight in each manager's 13F, not the share of Ionis Pharmaceuticals in (ions 0 04/01/26) the manager owns.